1887

Chapter 61 : Human Herpesviruses 6, 7, and 8

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Ebook: Choose a downloadable PDF or ePub file. Chapter is a downloadable PDF file. File must be downloaded within 48 hours of purchase

Buy this Chapter
Digital (?) $30.00

Preview this chapter:
Zoom in
Zoomout

Human Herpesviruses 6, 7, and 8, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555818722/9781555818715_CH61-1.gif /docserver/preview/fulltext/10.1128/9781555818722/9781555818715_CH61-2.gif

Abstract:

Herpesviruses 6, 7, and 8 are the most recently described members of the human herpesvirus family. Like other herpesviruses, they have the ability to establish a latent or persistent infection following primary infection, and reactivation may occur in healthy and immunocompromised people in response to different stimuli. A variety of methods are available or under development for the laboratory diagnosis of each virus, including viral isolation in cell culture, demonstration of viral antigens or nucleic acids in body fluids or tissues, and serology for detection of virus-specific antibodies. This chapter focuses on the immunologic and molecular diagnosis and monitoring of infections with human herpesvirus 6 (HHV-6), HHV-7, and HHV-8, and provides information on the unique features of the epidemiology and biological and clinical characteristics of these viruses.

Citation: Hodinka R. 2016. Human Herpesviruses 6, 7, and 8, p 578-590. In Detrick B, Schmitz J, Hamilton R (ed), Manual of Molecular and Clinical Laboratory Immunology, Eighth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555818722.ch61
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

References

/content/book/10.1128/9781555818722.ch61
1. Braun DK, Dominguez G, Pellett PE. 1997. Human herpesvirus 6. Clin Microbiol Rev 10:521567.[PubMed]
2. Dockrell DH. 2003. Human herpesvirus 6: molecular biology and clinical features. J Med Microbiol 52:518.[CrossRef].[PubMed]
3. Hall CB, Caserta MT, Schnabel KC, Boettrich C, McDermott MP, Lofthus GK, Carnahan JA, Dewhurst S. 2004. Congenital infections with human herpesvirus 6 (HHV6) and human herpesvirus 7 (HHV7). J Pediatr 145:472477.[CrossRef].[PubMed]
4. Flamand L, Komaroff AL, Arbuckle JH, Medveczky PG, Ablashi DV. 2010. Review, part 1: human herpesvirus-6-basic biology, diagnostic testing, and antiviral efficacy. J Med Virol 82:15601568.[CrossRef].[PubMed]
5. Caselli E, Di Luca D. 2007. Molecular biology and clinical associations of Roseoloviruses human herpesvirus 6 and human herpesvirus 7. New Microbiol 30:173187.[PubMed]
6. Krug LT, Pellett PE. 2014. Roseolovirus molecular biology: recent advances. Curr Opin Virol 9:170177.[CrossRef].[PubMed]
7. Pellett PE, Ablashi DV, Ambros PF, Agut H, Caserta MT, Descamps V, Flamand L, Gautheret-Dejean A, Hall CB, Kamble RT, Kuehl U, Lassner D, Lautenschlager I, Loomis KS, Luppi M, Lusso P, Medveczky PG, Montoya JG, Mori Y, Ogata M, Pritchett JC, Rogez S, Seto E, Ward KN, Yoshikawa T, Razonable RR. 2012. Chromosomally integrated human herpesvirus 6: questions and answers. Rev Med Virol 22:144155.[CrossRef].[PubMed]
8. Lee S-O, Brown RA, Razonable RR. 2012. Chromosomally integrated human herpesvirus-6 in transplant recipients. Transpl Infect Dis 14:346354.[CrossRef].[PubMed]
9. Stone RC, Micali GA, Schwartz RA. 2014. Roseola infantum and its causal human herpesviruses. Int J Dermatol 53:397403.[CrossRef].[PubMed]
10. Agut H. 2011. Deciphering the clinical impact of acute human herpesvirus 6 (HHV-6) infections. J Clin Virol 52:164171.[CrossRef].[PubMed]
11. Ward KN. 2005. Human herpesviruses-6 and -7 infections. Curr Opin Infect Dis 18:247252.[PubMed].[CrossRef]
12. Ablashi DV, Devin CL, Yoshikawa T, Lautenschlager I, Luppi M, Kühl U, Komaroff AL. 2010. Review Part 3: human herpesvirus-6 in multiple non-neurological diseases. J Med Virol 82:19031910.[CrossRef].[PubMed]
13. Yao K, Crawford JR, Komaroff AL, Ablashi DV, Jacobson S. 2010. Review part 2: human herpesvirus-6 in central nervous system diseases. J Med Virol 82:16691678.[CrossRef].[PubMed]
14. Ward KN. 2014. Child and adult forms of human herpesvirus 6 encephalitis: looking back, looking forward. Curr Opin Neurol 27:349355.[CrossRef].[PubMed]
15. Clark DA, Griffiths PD. 2003. Human herpesvirus 6: relevance of infection in the immunocompromised host. Br J Haematol 120:384395.[PubMed].[CrossRef]
16. Dockrell DH, Paya CV. 2001. Human herpesvirus-6 and -7 in transplantation. Rev Med Virol 11:2336.[PubMed].[CrossRef]
17. Zerr DM. 2012. Human herpesvirus 6 (HHV-6) disease in the setting of transplantation. Curr Opin Infect Dis 25:438444.[CrossRef].[PubMed]
18. Lautenschlager I, Razonable RR. 2012. Human herpesvirus-6 infections in kidney, liver, lung, and heart transplantation: review. Transpl Int 25:493502. review.[CrossRef].[PubMed]
19. Razonable RR. 2010. Infections due to human herpesvirus 6 in solid organ transplant recipients. Curr Opin Organ Transplant 15:671675.[CrossRef].[PubMed]
20. Razonable RR. 2013. Human herpesviruses 6, 7 and 8 in solid organ transplant recipients. Am J Transplant 13(Suppl 3):6777, quiz 77–78.[CrossRef].[PubMed]
21. Ward KN. 2005. The natural history and laboratory diagnosis of human herpesviruses-6 and -7 infections in the immunocompetent. J Clin Virol 32:183193.[CrossRef].[PubMed]
22. Agut H, Bonnafous P, Gautheret-Dejean A. 2015. Laboratory and clinical aspects of human herpesvirus 6 infections. Clin Microbiol Rev 28:313335.[CrossRef].[PubMed]
23. Lautenschlager I, Lappalainen M, Linnavuori K, Suni J, Höckerstedt K. 2002. CMV infection is usually associated with concurrent HHV-6 and HHV-7 antigenemia in liver transplant patients. J Clin Virol 25(Suppl 2):S57S61.[PubMed]
24. Volin L, Lautenschlager I, Juvonen E, Nihtinen A, Anttila VJ, Ruutu T. 2004. Human herpesvirus 6 antigenaemia in allogeneic stem cell transplant recipients: impact on clinical course and association with other beta-herpesviruses. Br J Haematol 126:690696.[CrossRef].[PubMed]
25. Marsh S, Kaplan M, Asano Y, Hoekzema D, Komaroff AL, Whitman JE Jr, Ablashi DV. 1996. Development and application of HHV-6 antigen capture assay for the detection of HHV-6 infections. J Virol Methods 61:103112.[PubMed].[CrossRef]
26. Krueger GRF, Ablashi DV, Josephs SF, Salahuddin SZ, Lembke U, Ramon A, Bertram G. 1991. Clinical indications and diagnostic techniques of human herpesvirus-6 (HHV-6) infection. In Vivo 5:287295.[PubMed]
27. Singh N, Carrigan DR. 1996. Human herpesvirus-6 in transplantation: an emerging pathogen. Ann Intern Med 124:10651071.[PubMed].[CrossRef]
28. Nielsen L, Vestergaard BF. 2002. A μ-capture immunoassay for detection of human herpes virus-6 (HHV-6) IgM antibodies in human serum. J Clin Virol 25:145154.[PubMed].[CrossRef]
29. Ward KN, Turner DJ, Parada XC, Thiruchelvam AD. 2001. Use of immunoglobulin G antibody avidity for differentiation of primary human herpesvirus 6 and 7 infections. J Clin Microbiol 39:959963.[CrossRef].[PubMed]
30. Thäder-Voigt A, Jacobs E, Lehmann W, Bandt D. 2011. Development of a microwell adapted immunoblot system with recombinant antigens for distinguishing human herpesvirus (HHV)6A and HHV6B and detection of human cytomegalovirus. Clin Chem Lab Med 49:18911898.
31. Hill JA, Sedlak RH, Jerome KR. 2014. Past, present, and future perspectives on the diagnosis of Roseolovirus infections. Curr Opin Virol 9:8490.[CrossRef].[PubMed]
32. Kainth MK, Caserta MT. 2011. Molecular diagnostic tests for human herpesvirus 6. Pediatr Infect Dis J 30:604605.[CrossRef].[PubMed]
33. Kidd IM, Clark DA, Bremner JAG, Pillay D, Griffiths PD, Emery VC. 1998. A multiplex PCR assay for the simultaneous detection of human herpesvirus 6 and human herpesvirus 7, with typing of HHV-6 by enzyme cleavage of PCR products. J Virol Methods 70:2936.[PubMed].[CrossRef]
34. Safronetz D, Humar A, Tipples GA. 2003. Differentiation and quantitation of human herpesviruses 6A, 6B and 7 by real-time PCR. J Virol Methods 112:99105.[PubMed].[CrossRef]
35. Secchiero P, Zella D, Crowley RW, Gallo RC, Lusso P. 1995. Quantitative PCR for human herpesviruses 6 and 7. J Clin Microbiol 33:21242130.[PubMed]
36. Gautheret-Dejean A, Manichanh C, Thien-Ah-Koon F, Fillet A-M, Mangeney N, Vidaud M, Dhedin N, Vernant JP, Agut H. 2002. Development of a real-time polymerase chain reaction assay for the diagnosis of human herpesvirus-6 infection and application to bone marrow transplant patients. J Virol Methods 100:2735.[PubMed].[CrossRef]
37. Flamand L, Gravel A, Boutolleau D, Alvarez-Lafuente R, Jacobson S, Malnati MS, Kohn D, Tang Y-W, Yoshikawa T, Ablashi D. 2008. Multicenter comparison of PCR assays for detection of human herpesvirus 6 DNA in serum. J Clin Microbiol 46:27002706.[CrossRef].[PubMed]
38. Karlsson T, Mannonen L, Loginov R, Lappalainen M, Höckerstedt K, Lautenschlager I. 2012. Development of a new quantitative real-time HHV-6-PCR and monitoring of HHV-6 DNAaemia after liver transplantation. J Virol Methods 181:2536.[CrossRef].[PubMed]
39. Cassina G, Russo D, De Battista D, Broccolo F, Lusso P, Malnati MS. 2013. Calibrated real-time polymerase chain reaction for specific quantitation of HHV-6A and HHV-6B in clinical samples. J Virol Methods 189:172179.[CrossRef].[PubMed]
40. de Pagter PJ, Schuurman R, de Vos NM, Mackay W, van Loon AM. 2010. Multicenter external quality assessment of molecular methods for detection of human herpesvirus 6. J Clin Microbiol 48:25362540.[CrossRef].[PubMed]
41. Nitsche A, Müller CW, Radonic A, Landt O, Ellerbrok H, Pauli G, Siegert W. 2001. Human herpesvirus 6A DNA Is detected frequently in plasma but rarely in peripheral blood leukocytes of patients after bone marrow transplantation. J Infect Dis 183:130133.[CrossRef].[PubMed]
42. Géraudie B, Charrier M, Bonnafous P, Heurté D, Desmonet M, Bartoletti M-A, Penasse C, Agut H, Gautheret-Dejean A. 2012. Quantitation of human herpesvirus-6A, -6B and -7 DNAs in whole blood, mononuclear and polymorphonuclear cell fractions from healthy blood donors. J Clin Virol 53:151155.[CrossRef]
43. Caserta MT, Hall CB, Schnabel K, Lofthus G, Marino A, Shelley L, Yoo C, Carnahan J, Anderson L, Wang H. 2010. Diagnostic assays for active infection with human herpesvirus 6 (HHV-6). J Clin Virol 48:5557.[CrossRef].[PubMed]
44. Achour A, Boutolleau D, Slim A, Agut H, Gautheret-Dejean A. 2007. Human herpesvirus-6 (HHV-6) DNA in plasma reflects the presence of infected blood cells rather than circulating viral particles. J Clin Virol 38:280285.[CrossRef].[PubMed]
45. Van den Bosch G, Locatelli G, Geerts L, Fagà G, Ieven M, Goossens H, Bottiger D, Oberg B, Lusso P, Berneman ZN. 2001. Development of reverse transcriptase PCR assays for detection of active human herpesvirus 6 infection. J Clin Microbiol 39:23082310.[CrossRef].[PubMed]
46. Bressollette-Bodin C, Nguyen TVH, Illiaquer M, Besse B, Peltier C, Chevallier P, Imbert-Marcille B-M. 2014. Quantification of two viral transcripts by real time PCR to investigate human herpesvirus type 6 active infection. J Clin Virol 59:9499.[CrossRef].[PubMed]
47. Secchiero P, Carrigan DR, Asano Y, Benedetti L, Crowley RW, Komaroff AL, Gallo RC, Lusso P. 1995. Detection of human herpesvirus 6 in plasma of children with primary infection and immunosuppressed patients by polymerase chain reaction. J Infect Dis 171:273280.[PubMed].[CrossRef]
48. Piret J, Boivin G. 2014. Antiviral drug resistance in herpesviruses other than cytomegalovirus. Rev Med Virol 24:186218.[CrossRef].[PubMed]
49. Sedlak RH, Cook L, Huang M-L, Magaret A, Zerr DM, Boeckh M, Jerome KR. 2014. Identification of chromosomally integrated human herpesvirus 6 by droplet digital PCR. Clin Chem 60:765772.[CrossRef].[PubMed]
50. Ward KN, Leong HN, Nacheva EP, Howard J, Atkinson CE, Davies NW, Griffiths PD, Clark DA. 2006. Human herpesvirus 6 chromosomal integration in immunocompetent patients results in high levels of viral DNA in blood, sera, and hair follicles. J Clin Microbiol 44:15711574.[CrossRef].[PubMed]
51. Hubacek P, Virgili A, Ward KN, Pohlreich D, Keslova P, Goldova B, Markova M, Zajac M, Cinek O, Nacheva EP, Sedlacek P, Cetkovsky P. 2009. HHV-6 DNA throughout the tissues of two stem cell transplant patients with chromosomally integrated HHV-6 and fatal CMV pneumonitis. Br J Haematol 145:394398.[CrossRef]
52. Frenkel N, Schirmer EC, Wyatt LS, Katsafanas G, Roffman E, Danovich RM, June CH. 1990. Isolation of a new herpesvirus from human CD4+ T cells. Proc Natl Acad Sci USA 87:748752.[PubMed].[CrossRef]
53. Ablashi DV, Berneman ZN, Kramarsky B, Whitman J Jr, Asano Y, Pearson GR. 1995. Human herpesvirus-7 (HHV-7): current status. Clin Diagn Virol 4:113.[PubMed].[CrossRef]
54. Clark DA, Freeland ML, Mackie LK, Jarrett RF, Onions DE. 1993. Prevalence of antibody to human herpesvirus 7 by age. J Infect Dis 168:251252.[PubMed].[CrossRef]
55. Leach CT. 2000. Human herpesvirus-6 and -7 infections in children: agents of roseola and other syndromes. Curr Opin Pediatr 12:269274.[PubMed].[CrossRef]
56. Kempf W, Müller B, Maurer R, Adams V, Campadelli Fiume G. 2000. Increased expression of human herpesvirus 7 in lymphoid organs of AIDS patients. J Clin Virol 16:193201.[PubMed].[CrossRef]
57. Berneman ZN, Ablashi DV, Li G, Eger-Fletcher M, Reitz MS Jr, Hung CL, Brus I, Komaroff AL, Gallo RC. 1992. Human herpesvirus 7 is a T-lymphotropic virus and is related to, but significantly different from, human herpesvirus 6 and human cytomegalovirus. Proc Natl Acad Sci USA 89:1055210556.[PubMed].[CrossRef]
58. Fernandez C, Boutolleau D, Manichanh C, Mangeney N, Agut H, Gautheret-Dejean A. 2002. Quantitation of HHV-7 genome by real-time polymerase chain reaction assay using MGB probe technology. J Virol Methods 106:1116.[PubMed].[CrossRef]
59. Zerr DM, Huang ML, Corey L, Erickson M, Parker HL, Frenkel LM. 2000. Sensitive method for detection of human herpesviruses 6 and 7 in saliva collected in field studies. J Clin Microbiol 38:19811983.[PubMed]
60. Ablashi DV, Chatlynne LG, Whitman JE Jr, Cesarman E. 2002. Spectrum of Kaposi's sarcoma-associated herpesvirus, or human herpesvirus 8, diseases. Clin Microbiol Rev 15:439464.[PubMed].[CrossRef]
61. Sarid R, Olsen SJ, Moore PS. 1999. Kaposi's sarcoma-associated herpesvirus: epidemiology, virology, and molecular biology. Adv Virus Res 52:139232.[PubMed].[CrossRef]
62. Dittmer DP, Damania B. 2013. Kaposi sarcoma associated herpesvirus pathogenesis (KSHV)—an update. Curr Opin Virol 3:238244.[CrossRef].[PubMed]
63. Gramolelli S, Schulz TF. 2015. The role of Kaposi sarcoma-associated herpesvirus in the pathogenesis of Kaposi sarcoma. J Pathol 235:368380.[CrossRef].[PubMed]
64. Dow DE, Cunningham CK, Buchanan AM. 2014. A review of human herpesvirus 8, the Kaposi's sarcoma-associated herpesvirus, in the pediatric population. J Pediatric Infect Dis Soc 3:6676.[CrossRef].[PubMed]
65. Edelman DC. 2005. Human herpesvirus 8—a novel human pathogen. Virol J 2:78. doi:10.1186/1743-422X-2-78[CrossRef].[PubMed] http://dx.doi.org/doi:10.1186/1743-422X-2-78
66. Kaplan LD. 2013. Human herpesvirus-8: kaposi sarcoma, multicentric Castleman disease, and primary effusion lymphoma. Hematology (Am Soc Hematol Educ Program) 2013:103108.[CrossRef].[PubMed]
67. Ammari ZA, Mollberg NM, Abdelhady K, Mansueto MD, Massad MG. 2013. Diagnosis and management of primary effusion lymphoma in the immunocompetent and immunocompromised hosts. Thorac Cardiovasc Surg 61:343349.[CrossRef].[PubMed]
68. Gantt S, Casper C. 2011. Human herpesvirus 8-associated neoplasms: the roles of viral replication and antiviral treatment. Curr Opin Infect Dis 24:295301.[CrossRef].[PubMed]
69. Cousins E, Nicholas J. 2014. Molecular biology of human herpesvirus 8: novel functions and virus-host interactions implicated in viral pathogenesis and replication. Recent Results Cancer Res 193:227268.[CrossRef].[PubMed]
70. Campbell DM, Rappocciolo G, Jenkins FJ, Rinaldo CR. 2014. Dendritic cells: key players in human herpesvirus 8 infection and pathogenesis. Front Microbiol 5:452.[CrossRef].[PubMed]
71. Tedeschi R, Dillner J, De Paoli P. 2002. Laboratory diagnosis of human herpesvirus 8 infection in humans. Eur J Clin Microbiol Infect Dis 21:831844.[CrossRef].[PubMed]
72. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, Moore PS. 1994. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266:18651869.[PubMed].[CrossRef]
73. Curreli F, Robles MA, Friedman-Kien AE, Flore O. 2003. Detection and quantitation of Kaposi's sarcoma-associated herpesvirus (KSHV) by a single competitive-quantitative polymerase chain reaction. J Virol Methods 107:261267.[PubMed].[CrossRef]
74. Lallemand F, Desire N, Rozenbaum W, Nicolas JC, Marechal V. 2000. Quantitative analysis of human herpesvirus 8 viral load using a real-time PCR assay. J Clin Microbiol 38:14041408.[PubMed]
75. Stamey FR, Patel MM, Holloway BP, Pellett PE. 2001. Quantitative, fluorogenic probe PCR assay for detection of human herpesvirus 8 DNA in clinical specimens. J Clin Microbiol 39:35373540.[CrossRef].[PubMed]
76. Simonelli C, Tedeschi R, Gloghini A, Talamini R, Bortolin MT, Berretta M, Spina M, Morassut S, Vaccher E, De Paoli P, Carbone A, Tirelli U. 2009. Plasma HHV-8 viral load in HHV-8-related lymphoproliferative disorders associated with HIV infection. J Med Virol 81:888896.[CrossRef].[PubMed]
77. Oksenhendler E, Carcelain G, Aoki Y, Boulanger E, Maillard A, Clauvel J-P, Agbalika F. 2000. High levels of human herpesvirus 8 viral load, human interleukin-6, interleukin-10, and C reactive protein correlate with exacerbation of multicentric castleman disease in HIV-infected patients. Blood 96:20692073.[PubMed]
78. Sayer R, Paul J, Tuke PW, Hargreaves S, Noursadeghi M, Tedder RS, Grant P, Edwards SG, Miller RF. 2011. Can plasma HHV8 viral load be used to differentiate multicentric Castleman disease from Kaposi sarcoma? Int J STD AIDS 22:585589.[CrossRef].[PubMed]
79. Zhu L, Wang R, Sweat A, Goldstein E, Horvat R, Chandran B. 1999. Comparison of human sera reactivities in immunoblots with recombinant human herpesvirus (HHV)-8 proteins associated with the latent (ORF73) and lytic (ORFs 65, K8.1A, and K8.1B) replicative cycles and in immunofluorescence assays with HHV-8-infected BCBL-1 cells. Virology 256:381392.[CrossRef].[PubMed]
80. Rabkin CS, Schulz TF, Whitby D, Lennette ET, Magpantay LI, Chatlynne L, Biggar RJ HHV-8 Interlaboratory Collaborative Group. 1998. Interassay correlation of human herpesvirus 8 serologic tests. HHV-8 Interlaboratory Collaborative Group. J Infect Dis 178:304309.[PubMed].[CrossRef]
81. Spira TJ, Lam L, Dollard SC, Meng Y-X, Pau CP, Black JB, Burns D, Cooper B, Hamid M, Huong J, Kite-Powell K, Pellett PE. 2000. Comparison of serologic assays and PCR for diagnosis of human herpesvirus 8 infection. J Clin Microbiol 38:21742180.[PubMed]
82. Burbelo PD, Issa AT, Ching KH, Wyvill KM, Little RF, Iadarola MJ, Kovacs JA, Yarchoan R. 2010. Distinct profiles of antibodies to Kaposi sarcoma-associated herpesvirus antigens in patients with Kaposi sarcoma, multicentric Castleman disease, and primary effusion lymphoma. J Infect Dis 201:19191922.[CrossRef].[PubMed]

Tables

Generic image for table
TABLE 1

Biological characteristics of HHV-6, HHV-7, and HHV-8

Citation: Hodinka R. 2016. Human Herpesviruses 6, 7, and 8, p 578-590. In Detrick B, Schmitz J, Hamilton R (ed), Manual of Molecular and Clinical Laboratory Immunology, Eighth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555818722.ch61
Generic image for table
TABLE 2

Epidemiologic and clinical characteristics of HHV-6, HHV-7, and HHV-8

Citation: Hodinka R. 2016. Human Herpesviruses 6, 7, and 8, p 578-590. In Detrick B, Schmitz J, Hamilton R (ed), Manual of Molecular and Clinical Laboratory Immunology, Eighth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555818722.ch61
Generic image for table
TABLE 3

Diagnostic methods for HHV-6, HHV-7, and HHV-8

Citation: Hodinka R. 2016. Human Herpesviruses 6, 7, and 8, p 578-590. In Detrick B, Schmitz J, Hamilton R (ed), Manual of Molecular and Clinical Laboratory Immunology, Eighth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555818722.ch61

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error